No positions in the markets we measure BY 07:30 ET
CCIR Compute Credit
Index Research
Credit · Tracked as filed as of 2026-08-25

Core Scientific

CCIR tracks 6 instruments issued by Core Scientific (CORZ): credit facility, bond, convertible, lease. Every row traces to a primary document.

Fixed coupons at issue
Filed coupon, by issue date · hollow = convertible · window Aug 2024 – May 2026
2% 4% 6% 8% 10% 20252026 conv '29 conv '31 notes '31
Floating spreads at signing
Filed spread over SOFR, by signing date · window Mar 2026 – Aug 2026
+1 +2 +3 Jul '26 Delayed-Draw Bridge… JPMorgan Revolving …

Capital stack by borrower

Which entity owes what, as filed. Facilities raised in a subsidiary sit on that subsidiary's assets; the parent's own paper sits beside them, senior to nothing below it.

BorrowerInstrumentSize $mRate
Core Scientific, Inc. JPMorgan Revolving Credit + Letter of Credit Facility 600 S+1.75%
Delayed-Draw Bridge Credit Agreement ($1.0B 364-day, MS/JPM) 1,000 S+2.50%
Core Scientific Finance I LLC 7.750% Senior Secured Notes due 2031 3,300 7.75%
Core Scientific (parent level) 0.00% Convertible Senior Notes due 2031 625 0%
3.00% Convertible Senior Notes due 2029 460 3%
Finance leases 0.88 Undisclosed

Instruments

JPMorgan Revolving Credit + Letter of Credit Facility

Credit facility $600m S+1.75% Entered 2026-08-25
Borrower
Core Scientific, Inc. (borrower)
Seniority
Senior secured, parent level
Maturity
2029-08-25 — Third anniversary of closing; extendable to the fourth anniversary (2030-08-25) at the Company's sole election
Collateral
First-priority lien on substantially all assets of the Company and the Guarantors
Lenders
JPMorgan Chase Bank, N.A. (admin + collateral agent) · Issuing banks and lenders party thereto
Pricing
Term SOFR (0.00% floor) + 1.75%
Terms
$100.0M senior secured revolving credit facility + $500.0M letter of credit facility; $0 outstanding under either at the 8/25/26 closing. Minimum liquidity covenant $150.0M (unrestricted cash + undrawn revolver commitments); each revolver borrowing conditioned on market capitalization of at least $3,000.0M at the prior market close.

Source: 8-K 8/27/26 (Credit Agreement filed as EX-10.1) · document

7.750% Senior Secured Notes due 2031

Bond $3,300m 7.75% Entered 2026-05-06
Borrower
Core Scientific Finance I LLC (issuer)
Seniority
Senior secured, project-style; guaranteed by 5 project subsidiaries (Austin, Denton, Dalton, Marble, Muskogee); parent completion guarantee, no parent debt guarantee
Maturity
2031-05-15
Collateral
1st liens on issuer + guarantor assets, equity pledge, parent collateral pending ring-fence transfer
Lenders
Morgan Stanley (lead) · J.P. Morgan (lead) · WSFS (trustee/collateral)
Terms
Issued at 99.25; ~11.5%/yr amortization after Nov 15, 2026 $3.30B outstanding 6/30/26; semi-annual amortization at an initial 11.50%/yr of original principal; $345M debt service reserve in restricted cash (Q2-26 10-Q).

Source: 8-K 5/6/26 with indenture; launch 8-K 4/21/26 (priced Apr 22) · document

Delayed-Draw Bridge Credit Agreement ($1.0B 364-day, MS/JPM)

Credit facility $1,000m S+2.50% Entered 2026-03-04 Resolved 2026-05-06
Borrower
Core Scientific, Inc. (borrower); material domestic subsidiary guarantors
Seniority
Senior secured
Maturity
2027-03-03 — 364 days from the 3/4/26 closing
Collateral
First-priority lien on substantially all assets of the Company and the Guarantors; 100% mandatory prepayment from asset sales, new debt, equity, insurance and development fees
Lenders
Morgan Stanley Senior Funding, Inc. (admin + collateral agent; initial $500M) · JPMorgan Chase Bank, N.A. (incremental $500M)
Pricing
Term SOFR (0% floor) + 2.50%
Terms
Initial $500M signed 3/4/26 (drawn 3/5); Amendment No. 1 (3/18/26, JPMorgan as amendment no. 1 term lender) added $500M, drawn same day — $1.0B total. Up to $7.5M commitment/exit fees; delayed-syndication fees beyond 106 days. REPAID IN FULL 2026-05-06 with proceeds of the $3.3B 7.750% Senior Secured Notes due 2031; all obligations released, discharged and satisfied (8-K 5/6/26).

Source: 8-K 3/6/26 (origination); 8-K 5/6/26 (repayment) · document

0.00% Convertible Senior Notes due 2031

Convertible $625m 0% Entered 2024-12-05
Seniority
Senior unsecured
Maturity
2031-06-15
Lenders
144A; U.S. Bank Trust Co. (trustee)
Pricing
Effective 0.4%; conversion ~$22.49

Source: 8-K 12/5/24; 10-Q; Q2-26 10-Q (6/30/26 balance), acc 0001839341-26-000014 · document

3.00% Convertible Senior Notes due 2029

Convertible $460m 3% Entered 2024-08-19
Seniority
Senior unsecured
Maturity
2029-09-01
Lenders
144A; U.S. Bank Trust Co. (trustee)
Pricing
Effective 3.7%; conversion ~$11.00

Source: 8-K 8/19/24; Q1-26 10-Q Note 6; Q2-26 10-Q (6/30/26 balance), acc 0001839341-26-000014 · document

Finance leases

Lease $0.88m Undisclosed
Seniority
Lease obligations
Maturity
Various
Collateral
Leased equipment
Terms
$876K finance leases 6/30/26; weighted-average remaining term 4.4y, discount rate 7.4% (Q2-26 10-Q). Commenced Q4 2025 (ROU assets of $1,916K obtained in exchange for lease obligations in 2025; none at 9/30/25); exact commencement date not disclosed.

Source: Q2-26 10-Q Note 6 Leases, filed 2026-07-28, acc 0001839341-26-000014; FY2025 10-K Note 7 · document

Collateral classes on this page: out, operator_campus, secured_undisclosed. The full ledger, with every issuer and the derived credit series, is on Compute Credit.